TP53 and acute lymphoblastic leukemia: Next, to directly evaluate whether the elektra mutation in Slfn2 attenuates T-ALL development and progression is by activation of the p53 pathway, we subjected the p53ERTAM/Slfn2eka/eka double transgenic mice to the ICN1 induced T-ALL model.